Fate Therapeutics, Inc. (FATE) Earnings
NASDAQ·Healthcare·Biotechnology
$2.07
+5.08%
Mkt Cap $230.79M
EPS — Estimate vs Actual
Mkt Cap
$230.79M
P/E
—
Fwd P/E
—
P/S
36.54
Rev TTM
—
EPS TTM
-$1.09
NASDAQ·Healthcare·Biotechnology
$2.07
+5.08%
Mkt Cap $230.79M
Mkt Cap
$230.79M
P/E
—
Fwd P/E
—
P/S
36.54
Rev TTM
—
EPS TTM
-$1.09